PROGNOSTIC FACTORS OF BREAST CÂNCER

Authors

  • Ana Lúcia Amaral Eisenberg Serviço de Anatomia Patológica, Hospital do Câncer, Instituto Nacional de Câncer e Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.
  • Sérgio Koifman Serviço de Anatomia Patológica, Hospital do Câncer, Instituto Nacional de Câncer e Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

Keywords:

Breast câncer, Prognostic factors

Abstract

Prognostic factors to breast câncer are either used to forecast disease evolution
pattern or to select patients who probably would benefit from receiving adjuvant
therapy. We carried out a literature review on the prognostic factors to breast câncer,
being axillary node metastasis the most acknowledged predictor associated to a poor
breast câncer evolution. Besides the number of axillary lymph nodes involved, other mentioned prognostic factors are age (the younger showing worst prognostic), tumor
size, hystologic grade, and vascular involvement, ali of them displaying independent
associated risks.

Downloads

Download data is not yet available.

References

1.AMERICAN CÂNCER SOCIETY, Surveillance

Research. Breast câncer facts and figures, 1997:

Estimated cases and deaths. Capturado em 1 ago

1999. On line. Disponível na Internet: http://

www.cancer.org/statistics/97bcff/who.htmI.

2.BARTH A. CRAIG PH. SILVERSTEIN MJ. Predictors of axillary lymph node metastases in patients with TI breast câncer. Câncer 1997; 79: 1918-22.

3.BERGER U, BETTELHEIM R, MANSI JL,

EASTON D, COOMBES RC, NEVILLE AM.

The relationship between micrometastases in the

bone marrow, histopathologic features of the

primary tumor in breast câncer and prognosis.

Am J Clin Pathol 1988; 90: 1-6.

4.BLOOM HJ, RICHARDSON WW. Histological

grading and prognosis in breast câncer. A study

of 1.049 cases of wich 359 have been followed

for 15 years. Br J Câncer 1957; 11: 359-77.

5.BUSCH E, KEMENY M. FREMGEN A, OSTEEN

RT, WINCHESTER DP, CLIVE RE. 1996. Pattems

of breast câncer care in the elderly. Câncer 1991;

78: 101-11.6.CALLE EE. MERVIS CA, WINGO PA, THUN MJ,

RODRIGUEZ C, HEATH CW Jr. Spontaneous

abortion and risk of fatal breast câncer in a

prospecti ve cohort of United States women. Câncer j 9

Causes Control 1995; 6: 460-8.

7.CHADHA M, CHABON AB. FRIEDMANN P,

VIKRAM B. Predictors of axillary lymph node

metastases in patients with TI breast câncer. A

multivariate analysis. Câncer 1994; 73: 350-3.

8.CHAGAS CR. Aspectos populacionais do câncer

de mama. Rev Bras Mastol 1994; 4: 11-6.20.

9.CHUNG M. CHANG HR. BLAND KL WANEBO

HJ. Younger women with breast carcinoma have a

poorer prognosis than older women. Câncer 1996;

77: 97-103.

10.CLAYTON F. Pathologic correlates of survival in 21.

378 lymph node-negative infiltrating ductal breast

carcinomas. Mitotic count is the best single

predictor. Câncer 1991; 68: 1309-17.22.

11.CLEMENTE CG. BORACCHIP, ANDREOLA S,

DEL VECCHIO M, VERONESI P, RILKE FO.

Peritumoral lymphatic invasion in patients with

node-negative mammary duct carcinoma. Câncer

1992; 69: 1396-403.

12.COLDITZ GA, ROSNER BA, SPEIZER FE. Risk 23.

factors for breast câncer according to family

hystory of breast câncer. For the Nurses' Health

Study Research Group. J Natl Câncer Inst 1996; 24.

88: 365-71.

13.DOTTO JE. Câncer bilateral de mama / Bilateral

câncer of the breast. Rev Argent Mastol 1985; 4:

13-8.

14.DOWLATSHAHIK. FAN M. SNIDER HG. HABIB

FA. Lymph node micrometastases from breast

carcinoma. Reviewing the dilemma. Câncer 1997; 25.

80: 1188-97.

15.ELSTON CW, ELLIS IO. Pathological prognostic

factors in breast câncer. I. The value of histological

grade in breast câncer: experience from a large 26.

study with long-term follow-up. Histopathology

1991; 19: 403-10.

16.ELSTON CW, ELLIS IO. Prognostic factors in

breast câncer. In: United States and Canadian

Academy of Pathology. Handout, Annual Meeting. 27.

1996; 1-73.

17.FELLER IP. BALLESTEROS GR. Câncer de

mama y embarazo / Câncer of the breast and

pregnancy (abstract). Boi Hospital San Juan Dios 28

1989; 36: 376-86.

18.FISHER ER, ANDERSON S, REDMOND C,

FISHER B. Pathologic findings from the National

Surgical Adjuvant Breast Project. (Protocol B-06).

10-year pathologic and clinicai prognostic

discriminants. Câncer 1993; 71: 2507-14.

FISHER ER, COSTANTINO J. FISHER B.

REDMOND C, COLLABORATING NATIONAL

SURGICAL ADJUVANT BREAST AND BOWEL

PROJECT INVESTIGATORS. Pathologic findings

from the National Surgical Adjuvant Breast Project

(Protocol 4). Discriminants for 15-year survival.

Câncer 1993; 71: 2141-50.

FUENTES JPP. MROCHKOVSKI AM.

BROCHADO MM. Incidência de factores de riesgo

en el câncer mamario de la mujer uruguaya/incidence

of risk factors for breast câncer in uruguayan

women. Cirurg Uruguay 1991; 61: 7-14.

GREENHOUGH RB. Varying degrees of

malignancy in câncer of the breast. J Câncer Res

1925; 9: 452-63.

HARDY EE. PINOTTIJA. OSIS MJD, FAÚNDES

A. Variáveis reproductivas e risco para câncer de

mama: estudo caso-controle desenvolvido no

Brasil/reproductive variables and the risk of breast

câncer: case-control study conducted in Brasil. Boi

Oficina Sanit Panam 1993; 115: 93-102.

HARTVEIT F. LILLENG PK. Breast câncer: two

micrometastatic variants in the axilla that differ in

prognosis. Histopathology 1996; 28: 241-6.

HORST JL. BOZKO LP. MAHFUS MA et al.

Câncer de mama: análise clínico-epidemiológica

de 892 casos do Hospital de Clínicas de Porto

Alegre/Breast câncer: clinical-epidemiologycal

analysis of 892 cases in the Hospital de Clínicas

de Porto Alegre. Rev Bras Ginecol Obst 1994;

16: 220-5.

LAURIA R. PERRONE F, CARLOMAGNO C et

al. The prognostic value of lymphatic and blood

vessel invasion in operable breast câncer. Câncer

1995; 76: 1772-8.

LEITNER SP. SWERN AS, WEINBERGER D,

DUNCAN LJ, HUTTER RVP. Predictors of

recurrence for patients with small (one centimeter

or less) localized breast câncer (Tia, b NO MO).

Câncer 1995; 76: 2266-74.

MALONE KE, DALING JR, WEISS NS,

MCKNIGHT B, WHITE E, VOIGT LF. Family

history and survival of young women with invasive

breast carcinoma. Câncer 1996; 78: 1417-25.

MAMBO NC, GALLAGER HS. Carcinoma of the

breast: prognostic significance of extranodal

extension of axillary nodes. Câncer 1977; 39:

2280-85.

29.MANSOUR EG. RAVDIN PM, DRESSLER L.

Prognostic factors in early breast carcinoma.

Câncer 1994; 74: 381-400.

30.MARCUS JN, WATSON P, PAGE DL et al.

Hereditary breast câncer. Pathobiology, prognosis,

and BRCA1 and BRCA2 gene linkage. Câncer 1996;

77: 697-709.

31.MENDONÇA GAS, ELUF-NETO J, ANDRADASERPA MJ et al. Organochorines and breast câncer:

a case-control study in Brazil. Int J Câncer 1999

(impress).

32.MIRRA AP, COLE P, MACMAHON B. Breast

câncer in an area of high parity: São Paulo, Brazil.

Câncer Res 1971; 31: 77-83.

33.NEWCOMB PA. STORER BE, LONGNECKER

MP. MITTENDORF R. GREENBERG ER,

WILLETT WC. Pregnancy termination in relation

to risk of breast câncer. J Am Med Assoc 1996;

275: 283-7.

34.OSBORNE CK. Prognostic factors in breast câncer.

Principies & Practice of Oncoiogy 1990; 4: 1-11.

35.PATEY DH, SCARFRW. The position of histology

in the prognosis of carcinoma of the breast. Lancet

1928; i: 801-4.

36.PEREIRA H, PINDER SE, SIBBERING DM et al.

Pathological prognostic factors in breast câncer. IV:

Should you be typer or a grader? A comparative study

of two histological prognostic features in operable

breast carcinoma. Histopathology 1995; 27: 219-26.

37.PINDER SE, ELLIS IO. GALEA M, 0'R0UKE S,

BLAMEY RW, ELSTON CW. Pathological

prognostic factors in breast câncer. III. Vascular

invasion: relationship with recurrence and survival

in a large study with long-term follow-up.

Histopathology 1994; 24: 41-7.

38.RECHT A, HOULIHAN MJ. Axillary lymph nodes

and breast câncer. A review. Câncer 1995; 76:

1491-512.

39.ROBBINS P, PINDER S, KLERK N et al.

Histological grading of breast carcinomas: a study

of interobserver agreement. Hum Pathol 1995; 26:

873-9.

40.SILVERSTEIN MJ. GIERSON ED, WAISMAN JR.

SENOFSKY GM. COLBURN WJ. GAMAGAMIP.

Axillary lymph node dissection for Tia breast

carcinoma. Is it indicated? Câncer 1994; 73: 664-7.

41.TABAR L, FAGERBERG G. CHEN HH. DUFFY

SW, GAD A. Tumor development, histology and

grade of breast cancers: prognosis and progression.

Int J Câncer 1996; 66: 413-9.

42.TELLES OS. Fatores prognósticos em câncer de

mama. Boi Soe Bras Mastol 1994; 6: 13-7.

43.WEIDNER N. Selected problems in breast

pathology. Prognostic factors in breast

carcinoma: which factors are important?

Seminars in Pathology. Handout. Califórnia

Society of Pathologists. San Diego, Califórnia,

EUA, 1994; 1-57.

"

44.WINCHESTER DP. Breast câncer in young

women. Surg Clin North Am 1996; 76: 279-87.

Downloads

Published

2026-07-28

How to Cite

Eisenberg, A. L. A., & Koifman, S. (2026). PROGNOSTIC FACTORS OF BREAST CÂNCER. Mastology, 10(2). Retrieved from https://mastology.org/journal/article/view/2058

Issue

Vol. 10 No. 2 (2000)

Section

Update

License

Copyright (c) 2026 Ana Lúcia Amaral Eisenberg, Sérgio Koifman

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.